Skip to main content

Javier Inserte Igual

-

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca
Cardiology
General Hospital
Javier Inserte Igual

Javier Inserte Igual

Javier Inserte Igual

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca
Cardiology
General Hospital

-

-

Projects

Papel diferencial de los canales TRPV4 en el desarrollo del remodelado cardiaco patológico frente al fisiológico: actuando sobre nuevas vías para el tratamiento de la insuficiencia cardiaca

IP: Begoña Benito Villabriga
Collaborators: Ignacio Ferreira González, Antonio Rodríguez Sinovas, Laia Yañez Bisbe, Marisol Ruiz Meana, Javier Inserte Igual
Funding agency: Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC/FEC-INV-BAS 20/016),
Duration: 01/01/2021 - 31/12/2021

PhotoHeart - High precision cardioprotective therapy: a photoswitchable approach to reduce the extension of myocardial infarction

IP: Javier Inserte Igual
Collaborators: José Antonio Barrabés Riu, Antonio Rodríguez Sinovas, Neus Bellera Gotarda, Marisol Ruiz Meana
Funding agency: Fundació "La Caixa"
Funding: 357850
Reference: HR21-00386
Duration: 15/11/2021 - 15/11/2025

ROLE OF CALPAINS AND REPROGRAMMING OF ESSENTIAL AMINO ACID METABOLISM IN VENTRICULAR HYPERTROPHY AND HEART FAILURE

IP: José Antonio Barrabés Riu
Collaborators: Rafael Rodríguez Lecoq, Mª Teresa Pastor Amorós, David Aluja Gonzalez, Vicens Serra Garcia, Natalia Gonzalez Otero, Javier Inserte Igual
Funding agency: Instituto de Salud Carlos III
Funding: 148225
Reference: PI20/01681
Duration: 01/01/2021 - 31/12/2024

Role of calpains in reprogramming of essential amino acid metabolism in ventricular remodeling and heart failure.

IP: Javier Inserte Igual
Collaborators: Role of calpains in reprogramming of essential amino acid metabolism in ventricular remodeling and heart failure., Miriam Izquierdo Sans
Funding agency: Fundació Institut de Recerca HUVH
Funding: 50649.27
Reference: VHIR/BEQUESPREDOC/2020/DELGADO
Duration: 01/04/2021 - 31/03/2024

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

Related professionals

Samuel Carmona Toledo

Samuel Carmona Toledo

Research assistant
Multidisciplinary Nursing Research Group
Read more
Diego Collado Gastalver

Diego Collado Gastalver

Senior researcher
Reconstructive Surgery of the Locomotor System
Read more
Deborah Pareto Onghena

Deborah Pareto Onghena

Head of group
Neuroradiology
Read more
Olga Maisterra Santos

Olga Maisterra Santos

Senior researcher
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.